08048035968
Premium Exporter of Genuine PAZONAT 200mg Tablets from India to Singapore – Orchard | Phoenix Exim

1. General Information

Pazonat 200 mg is an oral targeted cancer medicine containing pazopanib. It is primarily used to help control certain advanced cancers by interfering with molecular signals involved in tumour growth and the development of new blood vessels supplying tumours.

This medicine is prescription-only and should be used under the supervision of an oncologist or another qualified healthcare professional.

Manufacturer/Marketer: Natco Pharma Ltd.
Active ingredient: Pazopanib 200 mg
Dosage form: Film-coated tablet
Therapeutic class: Antineoplastic / Tyrosine Kinase Inhibitor

2. Product Information

Product DetailInformation
BrandPazonat 200 mg
Generic namePazopanib
Strength200 mg
Dosage formTablet
RouteOral
Manufacturer/MarketerNatco Pharma Ltd.
Therapeutic classTargeted anticancer medicine
Drug classTyrosine kinase/protein kinase inhibitor
Common pack30 tablets, depending on market/packaging

Pazonat 200 mg tablets contain pazopanib equivalent to 200 mg and are used as part of physician-directed treatment for specific cancers.

3. Uses of Pazonat 200 mg

Pazonat 200 mg may be prescribed for:

  • Advanced renal cell carcinoma (RCC), a type of kidney cancer.
  • Certain advanced soft-tissue sarcomas (STS) in adults, particularly in patients who have received prior chemotherapy, according to the applicable treatment indication.

The medicine should only be used for an indication and treatment plan determined by a qualified physician.

4. Benefits of Pazonat 200 mg

Pazonat 200 mg is a targeted anticancer therapy rather than a conventional chemotherapy medicine.

Potential treatment benefits include:

  • Helps slow the progression of certain advanced cancers.
  • Interferes with signalling pathways involved in cancer-cell growth.
  • Helps inhibit the formation of new blood vessels that tumours may need for growth.
  • May help control certain advanced kidney cancers and selected soft-tissue sarcomas.

The response to treatment varies between patients and should be evaluated through regular medical follow-up and appropriate investigations.

5. Side Effects of Pazonat 200 mg

Pazopanib can cause side effects ranging from mild to serious. Important adverse effects reported with pazopanib include:

  • High blood pressure
  • Diarrhea
  • Loss of appetite
  • Weight loss
  • Changes in taste
  • Hair or skin colour changes
  • Fatigue
  • Nausea or vomiting
  • Liver enzyme abnormalities
  • Bleeding
  • Changes in blood counts

More serious risks can include severe liver toxicity, QT-interval prolongation, cardiac dysfunction, blood clots or bleeding, gastrointestinal complications, and impaired wound healing.

6. Common Side Effects

Some commonly reported side effects include:

  • Diarrhea
  • High blood pressure
  • Decreased appetite
  • Weight loss
  • Taste changes
  • Hair discoloration
  • Skin or hair colour changes
  • Nausea
  • Fatigue

If side effects are persistent, severe, or unusual, the patient should contact their treating healthcare professional.

7. How to Use Pazonat 200 mg

Take Pazonat exactly according to your oncologist's instructions.

  • It is generally taken orally once daily when prescribed for standard adult treatment.
  • Take it without food, typically at least 1 hour before or 2 hours after eating.
  • Swallow the tablet whole with water; do not crush or chew it unless specifically instructed.
  • Try to take it at approximately the same time each day.
  • Do not change the dose or stop treatment without consulting your doctor.

The usual adult dose for pazopanib depends on the indication and individual patient factors. The FDA labeling lists 800 mg once daily for certain adult indications, while 200 mg once daily may be used in specific patients with moderate hepatic impairment. Therefore, the 200 mg tablet strength should not be interpreted as the patient's required daily dose.

8. How Pazonat 200 mg Works

Pazopanib is a tyrosine kinase inhibitor. It blocks several signalling proteins/receptors involved in tumour growth and angiogenesis (the formation of new blood vessels).

By interfering with these pathways, pazopanib can:

  1. Reduce signalling that promotes tumour-cell growth.
  2. Inhibit formation of new blood vessels supplying tumours.
  3. Help slow tumour growth and progression in cancers for which pazopanib is indicated.

9. Safety Advice for Pazonat 200 mg

Liver: Pazopanib can cause serious, potentially life-threatening liver toxicity. Liver-function tests should be performed before and during treatment as advised by the doctor.

Blood pressure: Blood pressure should be monitored regularly because hypertension is a common adverse effect.

Heart: Tell your doctor about existing heart problems. Pazopanib can affect cardiac function and may prolong the QT interval in susceptible patients.

Bleeding/clotting: Inform your doctor about any history of bleeding, blood clots, aneurysm, or vascular problems.

Pregnancy: Pazopanib can harm an unborn baby. Effective contraception should be discussed with the treating physician during treatment and for the recommended period afterward.

Breastfeeding: Breastfeeding is generally not recommended during pazopanib treatment.

Surgery: Tell your surgeon that you are taking pazopanib because it can affect wound healing.

Drug interactions: Inform your doctor about all prescription medicines, over-the-counter medicines, vitamins and supplements because pazopanib can interact with other medicines.

Do not self-medicate: Pazonat is a prescription anticancer medicine and should be taken only under appropriate medical supervision.

10. FAQs

Q1. What is Pazonat 200 mg used for?
Pazonat 200 mg contains pazopanib and is used for certain advanced kidney cancers and selected advanced soft-tissue sarcomas.

Q2. Is Pazonat 200 mg a chemotherapy medicine?
It is a targeted anticancer medicine belonging to the kinase inhibitor class rather than traditional cytotoxic chemotherapy.

Q3. Can I take Pazonat 200 mg with food?
Pazopanib is generally taken without food—at least 1 hour before or 2 hours after a meal. Follow your doctor's specific instructions.

Q4. Is Pazonat 200 mg available by prescription?
Yes. It is a prescription medicine and should be used under medical supervision.

Q5. Does Pazonat 200 mg cure cancer?
It is intended to help control or slow certain cancers; whether it produces a response depends on the cancer type and individual patient.

Q6. Can I stop Pazonat if I feel better?
No. Do not stop or change treatment without consulting your oncologist.

Q7. Does Pazonat affect the liver?
Yes. Pazopanib can cause significant liver toxicity, so regular liver-function monitoring is important.

Q8. What should I do if I miss a dose?
Follow the missed-dose instructions provided by your healthcare professional or the medicine's patient information. Do not take an extra dose unless specifically instructed.

11. Substitutes for Pazonat 200 mg

The appropriate substitute should be selected by an oncologist based on the patient's diagnosis, treatment history, liver function, other medicines and local availability.

Generic/therapeutic alternative:

  • Pazopanib 200 mg tablets from another approved manufacturer.

Other targeted anticancer medicines such as sunitinib, axitinib, cabozantinib or lenvatinib may be used for certain cancer situations, but they are not automatically interchangeable with Pazonat. The appropriate medicine depends on the specific cancer and treatment plan.

12. SEO Keywords

  • Pazonat 200 mg Tablets exporter from India
  • Pazonat 200 mg Tablets supplier from Nagpur India
  • Pazonat 200 mg Pazopanib Tablets exporter
  • Buy Pazonat 200 mg Tablets from India
  • Pazonat 200 mg Tablets pharmaceutical exporter
  • Pazonat 200 mg Tablets wholesale supplier
  • Pazonat 200 mg Tablets international supplier
  • Pazonat 200 mg Pazopanib supplier India
  • Pazopanib 200 mg Tablets exporter India
  • Pazopanib 200 mg medicine supplier
  • Pazonat 200 mg Tablets for kidney cancer
  • Pazonat 200 mg Tablets for renal cell carcinoma
  • Pazonat 200 mg Tablets soft tissue sarcoma
  • Pazonat 200 mg Tablets export to USA
  • Pazonat 200 mg Tablets export to UK
  • Pazonat 200 mg Tablets export to Australia
  • Pazonat 200 mg Tablets export to Singapore
  • Pazonat 200 mg Tablets export to Canada
  • Pazonat 200 mg Tablets export to South Korea
  • Pazonat 200 mg Tablets export to UAE
  • Phoenix Exim Pazonat 200 mg medicine exporter
  • Pazonat 200 mg pharmaceutical exporter from Nagpur India
Aug 20th, 2026 2:04 PM

Keywords